CROP PROTECTION RESEARCH
679
CHIMIA 2003, 57, No.11
Conclusions
[1] For a comprehensive review of the evolu-
tion of strobilurins see: H. Sauter, W.
Strobilurin analogs with meta-side-
chains are quite active against a variety of
commercially important plant pathogens.
Highest levels of activity were found for
diseases of cereal crops such as wheat foot
rot, wheat leaf rust, wheat glume blotch and
especially, wheat powdery mildew. Effica-
cy for the optimal compounds such as 21a
was displayed at 2 ppm and below for
various powdery mildews. Good activity
was also displayed on other important
pathogens such as apple scab, rice blast and
grape downy mildew.
We were able to show that meta-substi-
tuted strobilurins can have interesting lev-
els of fungicidal activity provided that a
substituent ortho to the pharmacophore was
also present. This work contradicted previ-
ous findings that the sidechain needed to be
in the ortho-position relative to the phar-
macophore. We surmise that the ortho-
group enforces a twist on the pharma-
cophore leading to a conformation suitable
for binding to the cytochrome bc1 complex,
similar to the effect of the traditional ortho-
side chain.
[2] W.F. Becker, G. von Jagow, T. Anke, W.
Steglich, FEBS Lett. 1981, 132, 329.
[3] R.J. Brown, B. Ashworth, J.E. Drumm,
D.A. Frasier, M.A. Hanagan, C. Happer-
sett, G.E. Koether, D.J. Robinson, K-M.
Sun, P. Wojtkowski, in ‘Synthesis and
Chemistry of Agrochemicals VI’, Eds.
D.R. Baker, J.G. Feynes, G.P. Lahm, T.P.
Selby, T.M. Stevenson, American Chemi-
cal Society, Washington D.C., pp.
327–341.
[4] K. Beautement, J.M. Clough, P.J. de
Fraine, C.R.A. Godfrey, Pestic. Sci. 1991,
31, 499.
[5] R.J. Brown, D.M.T. Chan, M.H. Howard,
D.J. Daniel, D.A. Clark, T.P. Selby (Du
Pont), World Patent Application WO
97/00612, 1997.
[6] Experimental details, physical properties
and fungicidal activity for compounds in
this paper are described in: M.P. Walker
(Du Pont), World Patent Application WO
99/28305, 1999.
[8] A similar transformation was subsequent-
ly reported by Novartis: R. Waditschatka
(Novartis), World Patent Application WO
00/63162, 2000.
Acknowledgements
We would like to thank all the members of
the plant disease control group at Du Pont for
providing the biological evaluations presented
here. Mitochondrial respiration assays were car-
ried out by Mr. Rand Schwartz and Dr. Douglas
Jordan. Analytical measurements were obtained
by Mr. James Doughty, Mr. John Groce and Ms.
Gina Blankenship. We also acknowledge helpful
discussions with Dr. David A. Clark and Dr.
Richard J. Brown. We would also like to thank
Dr. Darius J. Robinson and Ms. Berlin Stokes
(who synthesized the original thiadiazolyl tria-
zolinone (14a), which served as the comparison
point for our original investigation). We would
also like to thank Dr. James V. Hay and Dr.
William K. Moberg for their enthusiastic sup-
port of this project.
Received: September 15, 2003